Latest News

By buying an index fund, you can roughly match the market return with ease. But if you choose individual stocks with...

Most readers would already be aware that Südwestdeutsche Salzwerke's (FRA:SSH) stock increased significantly by 11...

To the annoyance of some shareholders, Carl Zeiss Meditec AG ( ETR:AFX ) shares are down a considerable 27% in the last...

With a price-to-earnings (or "P/E") ratio of 7.2x PWO AG ( ETR:PWO ) may be sending very bullish signals at the moment...

As global markets navigate mixed economic signals, with regions like Japan experiencing strong stock market gains and China tightening margin rules amidst a backdrop of trade tensions, Asia remains a focal point for investors seeking growth opportunities. In this context, companies with high insider ownership can offer unique insights into potential long-term value creation, as insiders often have a vested interest in the company's success and may be more aligned with shareholder interests.

As the Asian markets navigate a landscape marked by mixed performances in global indices and evolving economic conditions, investors are increasingly looking toward smaller, less-established companies for potential opportunities. While the term "penny stocks" might seem like a throwback to earlier market days, these stocks continue to represent an intriguing investment area due to their affordability and growth potential. By focusing on those with robust financials and clear growth...

PPC's (JSE:PPC) stock is up by a considerable 10.0% over the past week. However, in this article, we decided to focus...

With a price-to-earnings (or "P/E") ratio of 39x SPIE SA ( EPA:SPIE ) may be sending very bearish signals at the...

Studsvik AB (publ) ( STO:SVIK ) shares have had a really impressive month, gaining 28% after a shaky period beforehand...

One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks...

As global markets navigate a complex landscape of mixed earnings reports and geopolitical developments, small-cap stocks have been making notable strides, with indexes like the S&P MidCap 400 and Russell 2000 reaching record highs. In this dynamic environment, uncovering lesser-known opportunities can be particularly rewarding for investors seeking diversification and growth potential.

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...

LUDWIG BECK am Rathauseck - Textilhaus Feldmeier AG ( ETR:ECK ) shareholders have had their patience rewarded with a...

As Asian markets navigate a landscape marked by regulatory changes in China and political shifts in Japan, investors are increasingly seeking stability through dividend stocks. In this environment, selecting stocks with strong fundamentals and consistent dividend yields can offer a reliable income stream amidst market fluctuations.

Key Insights Significant control over Magyar Telekom Távközlési Nyilvánosan Müködö Részvénytársaság by public companies...

Most readers would already be aware that Fabrity's (WSE:FAB) stock increased significantly by 19% over the past month...

When we invest, we're generally looking for stocks that outperform the market average. And while active stock picking...

HomeTrust Bancshares FY 2025 Earnings Snapshot HomeTrust Bancshares (HTB) has posted its FY 2025 results with fourth quarter revenue of US$51.5 million and EPS of US$0.95, while trailing twelve month revenue came in at US$206.1 million and EPS at US$3.79, supported by net income of US$64.4 million over that period. The company reported quarterly revenue increasing from US$47.7 million in Q3 FY 2024 to US$51.5 million in Q4 FY 2025, with EPS over that same span ranging between US$0.77 and...

GlobalLogic, a Hitachi group company, expanded its partnership with Elektrobit to support the shift to software-defined vehicles across the global automotive sector. Hitachi Digital Services and adesso SE agreed to collaborate on cloud-based reliability solutions for asset-heavy industries, including energy and utilities, supported by HARC Labs pilot programs. Hitachi Vantara appointed Adrian Johnson as chief revenue officer to lead global sales for data infrastructure and hybrid cloud...

Phase 3 lymphoma data puts AbbVie (ABBV) oncology in focus AbbVie (ABBV) is drawing fresh attention after reporting Phase 3 results for epcoritamab in relapsed or refractory diffuse large B cell lymphoma, with the bispecific antibody improving progression free survival versus chemoimmunotherapy. See our latest analysis for AbbVie. Against this backdrop, AbbVie’s 1 day share price return of 0.91% and 7 day return of 0.63% sit alongside a softer 30 day share price return of a 4.67% decline and...

Biogen Inc. recently received European Commission marketing authorization for a new high dose regimen of SPINRAZA (nusinersen) to treat 5q spinal muscular atrophy, updating the therapy’s European Union label with an accelerated loading phase and modified maintenance dosing schedule. This approval is underpinned by the DEVOTE Phase 2/3 data showing statistically significant motor function improvements versus a matched untreated group, potentially enhancing SPINRAZA’s clinical profile and...

Trane Technologies (TT) is back on watch for investors after recent trading left the shares with a mixed return profile over the past month and past 3 months, alongside continued profitability. See our latest analysis for Trane Technologies. With the share price at $390.13, Trane Technologies has seen mixed momentum, with a 7 day share price return of 0.74% against a 90 day share price return of an 8.39% decline, while the 5 year total shareholder return of 191.78% contrasts with a softer 1...

Western Union (WU) is pushing further into digital finance with plans for a U.S. dollar stablecoin on the Solana blockchain, drawing fresh attention to a stock still tied to a shrinking legacy transfer business. See our latest analysis for Western Union. At a share price of US$9.41, Western Union has had a steady but muted run recently, with a 4.91% 3 month share price return and a 5 year total shareholder return of 40.78% decline. This suggests any excitement around the stablecoin plan is...

Wondering if Bio-Rad Laboratories at around US$305 a share is starting to look like value, or if the recent price action is a warning sign you should not ignore? The stock has been volatile, with a 5.2% decline over the last week, a 1.4% gain over the past month, and longer term returns of a 13.4% decline over 1 year, 35.9% decline over 3 years, and 46.1% decline over 5 years. These moves sit against a backdrop of ongoing interest in life sciences and diagnostics. In this space, investors...